Figure 1
Figure 1. Validation of methylation status of Eph/ephrin family genes in leukemia cell lines, primary ALL samples, and normal controls. (A) Methylation profile of Eph receptor/ephrin genes in leukemia cell lines and normal controls. Bisulfite pyrosequencing was performed to determine methylation status. Green indicates methylation density < 15%; yellow, methylation density between 15% and 29.99%; pink, methylation density between 30% and 59.99%; and red, methylation density > 60%. Methylation density > 15% was used to define a sample as methylated. (B) Methylation prevalence of 17 Eph/ephrin family genes in leukemia cell lines, ALL patients, and normal CD19+ controls. Methylation density > 15% was used as the cutoff for hypermethylation. Methylation prevalence was calculated as the percentage of positive methylated samples vs the total numbers studied for each gene. Error bars indicate range.

Validation of methylation status of Eph/ephrin family genes in leukemia cell lines, primary ALL samples, and normal controls. (A) Methylation profile of Eph receptor/ephrin genes in leukemia cell lines and normal controls. Bisulfite pyrosequencing was performed to determine methylation status. Green indicates methylation density < 15%; yellow, methylation density between 15% and 29.99%; pink, methylation density between 30% and 59.99%; and red, methylation density > 60%. Methylation density > 15% was used to define a sample as methylated. (B) Methylation prevalence of 17 Eph/ephrin family genes in leukemia cell lines, ALL patients, and normal CD19+ controls. Methylation density > 15% was used as the cutoff for hypermethylation. Methylation prevalence was calculated as the percentage of positive methylated samples vs the total numbers studied for each gene. Error bars indicate range.

Close Modal

or Create an Account

Close Modal
Close Modal